Disrupting this interaction could be neuroprotective in diseases such as AD, in which Aβ1–42 -RAGE interactions may contribute to the chronic inflammation, oxidative stress, and brain Aβ accumulation associated with disease pathology. The gene discussed is AGER; the disease is Alzheimer disease.